Overview
- Addresses currently debated issues concerning biotechnological inventions
- Written by internationally active experts
- Provides a basis for understanding biotech patentability
- Includes supplementary material: sn.pub/extras
Part of the book series: SpringerBriefs in Biotech Patents (BRIEFSBIOTECH)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (3 chapters)
Keywords
About this book
SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.
Authors and Affiliations
Bibliographic Information
Book Title: Biopatent Law: European vs. US Patent Law
Authors: Ulrich Storz, Martin Quodbach, Scott D. Marty, Derek E. Constantine, Matthew Parker
Series Title: SpringerBriefs in Biotech Patents
DOI: https://doi.org/10.1007/978-3-642-41293-6
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Author(s) 2014
Softcover ISBN: 978-3-642-41292-9Published: 04 December 2013
eBook ISBN: 978-3-642-41293-6Published: 19 November 2013
Series ISSN: 2192-9904
Series E-ISSN: 2192-9912
Edition Number: 1
Number of Pages: VIII, 69
Number of Illustrations: 2 b/w illustrations, 5 illustrations in colour
Topics: Molecular Medicine, IT Law, Media Law, Intellectual Property, Biochemistry, general